Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-04

Clinical Trial Update: Lessening Organ Dysfunction With VITamin C [Phase 3]

View source ↗

Summary

Phase 3 trial assessing high-dose vitamin C for reducing organ dysfunction in sepsis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Sepsis, Vitamin C | Phase 3 | Status: COMPLETED